135 related articles for article (PubMed ID: 31497356)
1. Natural killer cell-based adoptive transfer immunotherapy for pancreatic ductal adenocarcinoma in a
Hu S; Yang J; Shangguan J; Eresen A; Li Y; Ma Q; Yaghmai V; Velichko Y; Hu C; Zhang Z
Am J Cancer Res; 2019; 9(8):1757-1765. PubMed ID: 31497356
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-Kras
Hu S; Pan L; Shangguan J; Figini M; Eresen A; Sun C; Wang B; Ma Q; Hu C; Yaghmai V; Velichko Y; Yang J; Zhang Z
J Immunol Methods; 2019 Feb; 465():1-6. PubMed ID: 30468734
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.
Yang J; Hu S; Shangguan J; Eresen A; Li Y; Pan L; Ma Q; Velichko Y; Wang J; Hu C; Yaghmai V; Zhang Z
Am J Cancer Res; 2019; 9(11):2456-2468. PubMed ID: 31815046
[TBL] [Abstract][Full Text] [Related]
4. Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy.
Horvat NK; Karpovsky I; Phillips M; Wyatt MM; Hall MA; Herting CJ; Hammons J; Mahdi Z; Moffitt RA; Paulos CM; Lesinski GB
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38191243
[TBL] [Abstract][Full Text] [Related]
5. Dinaciclib prolongs survival in the
Yang J; Hu S; Shangguan J; Eresen A; Li Y; Ma Q; Yaghmai V; Benson Iii AB; Zhang Z
Am J Transl Res; 2020; 12(3):1031-1043. PubMed ID: 32269732
[TBL] [Abstract][Full Text] [Related]
6. Black raspberries suppress pancreatic cancer through modulation of NKp46
Pan P; Zhu Z; Oshima K; Aldakkak M; Tsai S; Huang YW; Dong W; Zhang J; Lin CW; Wang Y; Yearsley M; Yu J; Wang LS
Food Front; 2020 Mar; 1(1):70-82. PubMed ID: 32368735
[TBL] [Abstract][Full Text] [Related]
7. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.
Fendrich V; Sparn M; Lauth M; Knoop R; Plassmeier L; Bartsch DK; Waldmann J
Pancreatology; 2013; 13(5):502-7. PubMed ID: 24075515
[TBL] [Abstract][Full Text] [Related]
9. MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma.
Eresen A; Yang J; Shangguan J; Li Y; Hu S; Sun C; Velichko Y; Yaghmai V; Benson AB; Zhang Z
J Transl Med; 2020 Feb; 18(1):61. PubMed ID: 32039734
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancer.
Waldmann J; Fendrich V; Reichert M; Hecker A; Bartsch DK; Padberg W; Holler JPN
J Surg Res; 2018 Mar; 223():230-236. PubMed ID: 29433879
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancer.
D'Alincourt Salazar M; Manuel ER; Tsai W; D'Apuzzo M; Goldstein L; Blazar BR; Diamond DJ
Oncoimmunology; 2016 Jun; 5(6):e1160184. PubMed ID: 27471630
[TBL] [Abstract][Full Text] [Related]
12. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
Mace TA; Shakya R; Pitarresi JR; Swanson B; McQuinn CW; Loftus S; Nordquist E; Cruz-Monserrate Z; Yu L; Young G; Zhong X; Zimmers TA; Ostrowski MC; Ludwig T; Bloomston M; Bekaii-Saab T; Lesinski GB
Gut; 2018 Feb; 67(2):320-332. PubMed ID: 27797936
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
14. Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In Vivo.
Li J; Qian W; Qin T; Xiao Y; Cheng L; Cao J; Chen X; Ma Q; Wu Z
Comput Struct Biotechnol J; 2019; 17():498-506. PubMed ID: 31011408
[TBL] [Abstract][Full Text] [Related]
15. Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.
Lee JW; Komar CA; Bengsch F; Graham K; Beatty GL
Curr Protoc Pharmacol; 2016 Jun; 73():14.39.1-14.39.20. PubMed ID: 27248578
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry.
An X; Ouyang X; Zhang H; Li T; Huang YY; Li Z; Zhou D; Li QX
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30371656
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging biomarkers for pulsed focused ultrasound treatment of pancreatic ductal adenocarcinoma.
Maloney E; Wang YN; Vohra R; Son H; Whang S; Khokhlova T; Park J; Gravelle K; Totten S; Hwang JH; Lee D
World J Gastroenterol; 2020 Mar; 26(9):904-917. PubMed ID: 32206002
[TBL] [Abstract][Full Text] [Related]
20. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy.
Torres MP; Rachagani S; Souchek JJ; Mallya K; Johansson SL; Batra SK
PLoS One; 2013; 8(11):e80580. PubMed ID: 24278292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
